Cargando…
Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas
Up to 86% of uterine leiomyomas harbour somatic mutations in mediator complex subunit 12 (MED12). These mutations have been associated with conventional histology, smaller tumour size, and larger number of tumours within the uterus. Prior studies, with limited sample sizes, have failed to detect ass...
Autores principales: | Heinonen, Hanna-Riikka, Pasanen, Annukka, Heikinheimo, Oskari, Tanskanen, Tomas, Palin, Kimmo, Tolvanen, Jaana, Vahteristo, Pia, Sjöberg, Jari, Pitkänen, Esa, Bützow, Ralf, Mäkinen, Netta, Aaltonen, Lauri A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430741/ https://www.ncbi.nlm.nih.gov/pubmed/28432313 http://dx.doi.org/10.1038/s41598-017-01199-0 |
Ejemplares similares
-
Global metabolomic profiling of uterine leiomyomas
por: Heinonen, Hanna-Riikka, et al.
Publicado: (2017) -
MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas
por: Kämpjärvi, Kati, et al.
Publicado: (2016) -
Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability
por: Välimäki, Niko, et al.
Publicado: (2018) -
Parity associates with chromosomal damage in uterine leiomyomas
por: Kuisma, Heli, et al.
Publicado: (2021) -
Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas
por: Välimäki, Niko, et al.
Publicado: (2023)